(Q39381056)

11 September 2017

title

Pentoxifylline in the treatment of actinic prurigo. A preliminary report of 10 patients (English)

1 reference

11 September 2017

1 reference

Bertha Torres-Alvarez

series ordinal

1

1 reference

11 September 2017

Juan Pablo Castanedo-Cazares

series ordinal

2

1 reference

11 September 2017

Benjamin Moncada

series ordinal

3

1 reference

11 September 2017

publication date

1 January 2004

1 reference

11 September 2017

1 reference

11 September 2017

volume

208

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

198-201

1 reference

Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.

11 September 2017

cites work

1 reference

Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporin A.

21 January 2018

1 reference

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

21 January 2018

1 reference

Pentoxifylline Inhibits Certain Constitutive and Tumor Necrosis Factor-α-Induced Activities of Human Normal Dermal Fibroblasts

21 January 2018

1 reference

Pentoxifylline attenuates UVB-induced cutaneous erythema

21 January 2018

1 reference

Pentoxifylline in intractable recurrent aphthous stomatitis: an open trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000077299

1 reference

11 September 2017

1 reference